This is a Validated Antibody Database (VAD) review about human EIF6, based on 6 published articles (read how Labome selects the articles), using EIF6 antibody in all methods. It is aimed to help Labome visitors find the most suited EIF6 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EIF6 synonym: CAB; EIF3A; ITGB4BP; b(2)gcn; eIF-6; p27(BBP); p27BBP; eukaryotic translation initiation factor 6; B4 integrin interactor; eukaryotic translation initiation factor 3A; p27 beta-4 integrin-binding protein
Santa Cruz Biotechnology
mouse monoclonal (A-12) |
| Santa Cruz Biotechnology EIF6 antibody (Santa Cruz Biotechnology, sc-390441) was used in immunocytochemistry on human samples (fig 7a). Mol Cell Biol (2015) ncbi |
Cell Signaling Technology
rabbit monoclonal (D51F4) |
| Cell Signaling Technology EIF6 antibody (Cell Signaling, 3411) was used in western blot on human samples at 1:2000 (fig 3a). Cell Res (2017) ncbi |
rabbit monoclonal (D51F4) |
| In order to study mRNA transcript production during the integrated stress response, Cell Signaling Technology EIF6 antibody (Cell Signaling Technology, 3411) was used in immunocytochemistry on human samples at 1:1000. elife (2015) ncbi |
rabbit monoclonal (D51F4) |
| Cell Signaling Technology EIF6 antibody (Cell Signaling, 3411) was used in western blot on rat samples at 1:1000 (fig 2f). Eur J Pharmacol (2015) ncbi |
rabbit monoclonal (D51F4) |
| Cell Signaling Technology EIF6 antibody (Cell Signaling Technology, 3411) was used in western blot on human samples . Mol Cell Biol (2014) ncbi |
BD Biosciences
mouse monoclonal (23/eIF-6) |
| In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences EIF6 antibody (BD, 23) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments